Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-08

Clinical Trial Update: The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for FRD Folate Receptor-Mediated Staining Solution in detecting cervical intraepithelial neoplasia grade 2/3; current status is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FRD Folate Receptor-Mediated Staining Solution (Folate receptor-mediated staining solution)

Snippet

Sponsor: GY Highland Biotech LLC | Conditions: Cervical Intraepithelial Neoplasia Grade 2/3 | Phase 3 | Status: UNKNOWN